CalciMedica, Inc. — Director's Dealing 2020

Sep 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GRAYBUG VISION, INC. (GRAY)
CIK: 0001534133
Period of Report: 2020-09-29

Reporting Person: SHAFFER CHRISTY L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-29	Common Stock	C	1586490	—	Acquired	1586490	Indirect
2020-09-29	Common Stock	P	18750	$16.00	Acquired	1605240	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-29	Series A-2 Preferred Stock	$	C	193224	Disposed		Common Stock (193224)	Indirect
2020-09-29	Series B Preferred Stock	$	C	1242120	Disposed		Common Stock (1242120)	Indirect
2020-09-29	Series C Preferred Stock	$	C	151146	Disposed		Common Stock (151146)	Indirect

Footnotes

F1: Each share of the Issuer's Series A-2 Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 1 share of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration and has no expiration date.

F2: These securities are held of record by Hatteras Venture Partners IV SBIC, L.P. ("HVP IV SBIC"). Hatteras Venture Advisors IV SBIC, L.L.C. ("HVA IV SBIC") is the general partner of HVP IV SBIC. The managing members of HVA IV SBIC include: Robert Ingram, Douglas Reed, Clay Thorp, John Crumpler and Kenneth Lee. These managing members share voting and dispositive power over the securities directly held by HVP IV SBIC. The Reporting Person is a partner of Hatteras Venture Partners and disclaims beneficial ownership of the securities held by HVP IV SBIC except to the extent of her pecuniary interest therein, if any.